Experiment 346905

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

STREPTOMYCES ANTIBIOTIC EI-1511-3

Details

PropertyValue
Pharmacology
INTERLEUKIN-1-BETA RELEASE INHIBITION
OrganismEmpty organism
CitationTANAKA,T: TSUKUDA,E: UOSAKI,Y: MATSUDA,Y:. (1996). EI-1511-3, -5 AND EI-1625-2, NOVEL INTERLEUKIN-1-BETA CONVERTING ENZYME INHIBITORS PRODUCED BY STREPTOMYCES SP. E-1511 AND E-1625. III. BIOCHEMICAL PROPERTIES OF EI-1511-3, -5 AND EI-1625-2.. 49(11)
Amount utilized
Compound isolated
DiseaseVS.LPS-INDUCED IL1-BETA SECRETION.
Dose amount11.0 MICROMOLS
Number4
Qualitative resultACTIVE
AnimalCELL CULTURE
Dose expressionIC50